trial

Movement Disorders Caused by Antipsychotic Drugs in Older Patients

NCTId NCT00255879
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1 · Completed
Enrollment 250
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2004-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1
Status
Completed
Enrollment
250
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
1999-01
Primary completion
2004-08
Eligibility
ALL · 40 Years

Interventions & indications

Drugs
QuetiapineRisperidoneOlanzapine

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Dilip V. Jeste, MDPrincipal Investigator

Sites

1 total
San Diego, United States

Facts & assertions

4 sourced
Enrollment
250
Phase
PHASE1
Primary Completion Date
2004-08
Status
COMPLETED
relationships
The graph out of here
drug
Quetiapine
drug
Risperidone
drug
Olanzapine
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Dyskinesia, Drug-Induced
indication
Dyskinesia, Drug-Induced
indication
Tardive Dyskinesia
indication
investigator
Dilip V. Jeste, MD
person